Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single (Investigator)-Blind, Randomized, Parallel-group Study to Evaluate the Use of Various Assessments of Common Cold Symptoms for Proof of Efficacy of CMS016317

NCT03831763 is registered in ClinicalTrials.gov with Enzymatica AB as lead sponsor.

NCT NCT03831763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03831763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single (Investigator)-Blind, Randomized, Parallel-group Study to Evaluate the Use of Various Assessments of Common Cold Symptoms for Proof of Efficacy of CMS016317
Lead sponsor
Enzymatica AB
Phase
Not applicable
Overall status
Completed
Start date
January 25, 2018
Completion date
June 5, 2018
Enrollment
400 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

common cold